476 related articles for article (PubMed ID: 21521057)
1. Outcomes of reintervention for recurrent disease after percutaneous iliac angioplasty and stenting.
Davies MG; Bismuth J; Saad WE; Naoum JJ; Peden EK; Lumsden AB
J Endovasc Ther; 2011 Apr; 18(2):169-80. PubMed ID: 21521057
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting.
Davies MG; Saad WA; Bismuth JX; Peden EK; Naoum JJ; Lumsden AB
J Vasc Surg; 2009 Apr; 49(4):946-52. PubMed ID: 19217748
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
4. Midterm outcome of balloon-expandable polytetrafluoroethylene-covered stents in the treatment of iliac artery chronic occlusive disease.
Grimme FA; Spithoven JH; Zeebregts CJ; Scharn DM; Reijnen MM
J Endovasc Ther; 2012 Dec; 19(6):797-804. PubMed ID: 23210879
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of the Endovascular Treatment of Stenotic Lesions versus Chronic Total Occlusions in the Iliac Sector.
Revuelta Suero S; Martínez López I; Hernández Mateo M; Marqués de Marino P; Cernuda Artero I; Cabrero Fernández M; Serrano Hernando FJ
Ann Vasc Surg; 2016 Jul; 34():157-63. PubMed ID: 27179982
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance.
Connors G; Todoran TM; Engelson BA; Sobieszczyk PS; Eisenhauer AC; Kinlay S
Catheter Cardiovasc Interv; 2011 Jun; 77(7):1055-62. PubMed ID: 20853355
[TBL] [Abstract][Full Text] [Related]
7. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions.
Tewksbury R; Taumoepeau L; Cartmill A; Butcher A; Cohen T
Vascular; 2015 Dec; 23(6):630-6. PubMed ID: 25819513
[TBL] [Abstract][Full Text] [Related]
9. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
[TBL] [Abstract][Full Text] [Related]
10. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
[TBL] [Abstract][Full Text] [Related]
11. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.
Ichihashi S; Higashiura W; Itoh H; Sakaguchi S; Nishimine K; Kichikawa K
J Vasc Surg; 2011 Apr; 53(4):992-9. PubMed ID: 21215582
[TBL] [Abstract][Full Text] [Related]
14. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.
Chen BL; Holt HR; Day JD; Stout CL; Stokes GK; Panneton JM
J Vasc Surg; 2011 Feb; 53(2):367-73. PubMed ID: 21030201
[TBL] [Abstract][Full Text] [Related]
15. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.
Piazza M; Ricotta JJ; Bower TC; Kalra M; Duncan AA; Cha S; Gloviczki P
J Vasc Surg; 2011 Aug; 54(2):402-11. PubMed ID: 21531527
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of stent-supported subintimal angioplasty in the treatment of long iliac artery occlusions.
Ko YG; Shin S; Kim KJ; Kim JS; Hong MK; Jang Y; Shim WH; Choi D
J Vasc Surg; 2011 Jul; 54(1):116-22. PubMed ID: 21334171
[TBL] [Abstract][Full Text] [Related]
17. Endovascular treatment of hepatic artery stenosis after liver transplantation.
Hamby BA; Ramirez DE; Loss GE; Bazan HA; Smith TA; Bluth E; Sternbergh WC
J Vasc Surg; 2013 Apr; 57(4):1067-72. PubMed ID: 23332988
[TBL] [Abstract][Full Text] [Related]
18. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
[TBL] [Abstract][Full Text] [Related]
19. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
20. Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
Robinson WP; Nguyen LL; Bafford R; Belkin M
J Vasc Surg; 2011 Mar; 53(3):651-7. PubMed ID: 21129908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
